15 Jan Sano Genetics
Charlotte Guzzo, Ph.D., Co-Founder and Chief Operating Officer
April 29 | 4:00pm | Salone dei Cavalieri, Section 1
Cambridge, UK
(Private)
For cell and gene therapy developers who rely on precise, genotype-driven patient identification, Sano Genetics is the precision patient platform that unifies recruitment, eligibility screening, at-home genetic testing, and long-term engagement in one compliant, modular ecosystem. Unlike CROs or point solutions that only address isolated steps, Sano’s 360° platform reduces screen failures, accelerates enrollment, and builds reusable, consented, genotype-tagged cohorts that support both clinical development and post-approval evidence generation. We create the missing patient data layer for modern drug development, supporting early natural history insights, recontact across programs, and real-world follow-up for durability and safety. By maintaining continuous connection from first touchpoint through long-term engagement, Sano helps gene therapy and rare disease sponsors lower operational risk, shorten timelines, and ensure valuable data and patient relationships carry forward across studies and programs.
